A Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of V24343 on Blood Pressure and Weight in Obese Subjects

Trial Profile

A Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of V24343 on Blood Pressure and Weight in Obese Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jul 2011

At a glance

  • Drugs V 24343 (Primary)
  • Indications Obesity
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Jul 2011 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 22 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Mar 2009 Planned end date changed from 1 Jan 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top